Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study
Abstract Background: This Phase I randomized controlled trial aimed to assess the safety and tolerability of cannabidiol (CBD) and alcohol…
Abstract Background: This Phase I randomized controlled trial aimed to assess the safety and tolerability of cannabidiol (CBD) and alcohol…
Abstract Comorbid substance use disorders (SUDs) are common but difficult to study due to the complex, interacting and overlapping mechanisms…
Abstract Aims: Previous studies have demonstrated that the endocannabinoid system plays a significant role in the development of alcohol use…
Abstract Background: Attention-Deficit/Hyperactivity Disorder (ADHD) in adulthood is frequently associated with complex psychiatric comorbidity, including high rates of Substance Use…
Abstract Introduction: 27.1 million adults in the United States have alcohol use disorder (AUD). However, current medications for AUD have…
Abstract Background: Comorbidity between alcohol use disorder (AUD) and post‐traumatic stress disorder (PTSD) exacerbates symptom severity and worsens treatment outcomes.…
Abstract Background: Sleep-promotion is one of the most common reasons people use cannabis. Previous studies, primarily among young adults, suggest…
Abstract Rationale: Negative affect is a key factor in Alcohol Use Disorder (AUD) associated with craving and relapse risk that…
Abstract With increasing substance misuse among older adults, we examined the question of whether older adults may be less likely…
Abstract Introduction: Cannabidiol (CBD) has recently gained attention for its potential therapeutic effects in substance use disorders, including Alcohol Use…